Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Merger & Restructuring

Every merger & restructuring announcement on NSE and BSE that our alert engine sent, newest first.

19:24 IST NSE
Merger & RestructuringUnihealth Hospitals Ltd UNIHEALTH

Unihealth Hospitals Merger & Restructuring Worth ₹65.04 Cr

UniHealth Hospitals approved a Rs.65.04 Crore share swap to acquire 49.81% of Victoria Hospital Limited, Uganda. The deal, to be completed by March 2027, aims to strengthen its international healthcare platform.

Value
₹65.04 Cr
Execution
By end of financial year 31.03.2027
19:20 IST BSE
Merger & RestructuringAnantam Highways Trust ANANTAM

Anantam Highways Trust Merger & Restructuring Worth ₹1,894 Cr

Anantam Highways Trust approved acquiring 7 highway assets for up to ₹1893.72 Cr. The acquisition will be funded via preferential unit issuance and cash.

Value
₹1,894 Cr
Execution
Subject to satisfaction of customary conditions and receipt of approvals.
18:38 IST NSE
Merger & RestructuringKCK Industries Ltd KCK

KCK Industries Merger & Restructuring

KCK Industries approved a demerger to transfer land to its wholly-owned subsidiary, KCK Infratech. The restructuring aims to enhance operational efficiency for IT infrastructure development.

13:28 IST BSE
Merger & RestructuringCapitalNumbers Infotech Ltd 544343

CapitalNumbers Infotech Merger & Restructuring Worth ₹40 Cr

CapitalNumbers Infotech Ltd announced a cash acquisition of Epitome Cloud Inc for approx. ₹40 Crore. The deal will give CapitalNumbers 100% ownership of the US‑based technology firm.

Value
₹40.00 Cr
Execution
8 to 12 weeks
12:42 IST NSE
Merger & RestructuringSandhar Technologies Ltd SANDHAR

Sandhar Technologies Merger & Restructuring Worth ₹1.62 Cr

Sandhar Technologies Ltd will acquire Clean Renewable Energy HR 1B Pvt Ltd for ₹1.62 crore in cash. The deal, expected to close within two months, adds energy capacity.

Value
₹1.62 Cr
Execution
2 months from execution of Share Subscription and Shareholders Agreement
10:02 IST BSE
Merger & RestructuringEmcure Pharmaceuticals Ltd EMCURE

Emcure Pharmaceuticals Merger & Restructuring Worth ₹335 Cr

Emcure Pharma announced that its subsidiary Marcan will acquire Mantra Pharma for CAD $50 million (≈ ₹335 Crore). The acquisition makes Mantra a wholly‑owned step‑down subsidiary of Marcan.

Value
₹335.0 Cr